The information supplied on this website and in our information materials is based on published research plus, where that is not available, the experience and expertise of our medical advisory panel members and other experts in the field. You may also find our report, Screening will save newborn lives: A case for the introduction of routine screening for GBS in late pregnancy, of interest.
For a more comprehensive list of published papers on group B Strep, click this link to PubMed – there are over 10,000 papers listed.
Below are published papers that are particularly important in increasing our knowledge about group B Strep. Papers are listed in chronological order, with links to the abstracts or the full papers where possible.
Neonatal morbidity associated with maternal Group B Streptococcal colonization in individuals undergoing planned cesarean delivery. Christina A Herrera 1, Jessica A McPherson 2, Catherine J Vladutiu 3, Marcela C Smid 4 5. Observational Study J Matern Fetal Neonatal Med. 2023 Dec;36(1):2183740. doi: 10.1080/14767058.2023.2183740.
20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention. Proma Paul 1, Bronner P Gonçalves 1, Kirsty Le Doare 2 3, Joy E Lawn 1Curr Opin Pediatr. 2023 Apr 1;35(2):223-230. doi: 10.1097/MOP.0000000000001223. Epub 2023 Feb 16.
Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial. Majela Gonzalez-Miro 1, Andrzej Pawlowski 1, Janne Lehtonen 2, Duojia Cao 1, Sara Larsson 1, Michael Darsley 2, Geoff Kitson 2, Per B Fischer 2, Bengt Johansson-Lindbom. iScience. 2023 Feb 21;26(3):106261. doi: 10.1016/j.isci.2023.106261. eCollection 2023 Mar 17.
Neonatal Group B Streptococcal Infection in Australia: A Case-control Study. Marianne Yanni 1 2, Michael Stark 2 3, Laura Francis 4, Joshua R Francis 4 5, Mark McMillan 2 6, Rob Baird 7, Paul T Heath 8, Alex Gordon 1, James Riccardione 7, Angela Wilson 7, Rebecca Lee 4, Kathrina Chooi 6, Olivia-Paris Quinn 6, Helen S Marshall 2 3 6. Pediatr Infect Dis J. 2023 Mar 16. doi: 10.1097/INF.0000000000003881. Online ahead of print.
Maternity care provider acceptance of a future Group B Streptococcus vaccine – A qualitative study in three countries. Sarah Geoghegan 1, Francia Acosta 2, Laura C Stephens 3, Hanah Gillan 3, Sandra Valera 4, Richard J Drew 5, Maeve Eogan 6, Adam J Ratner 7, Andrew P Steenhoff 8, Karina M Butler 9, Kristen A FeemsterVaccine. 2023 Mar 17;41(12):2013-2021. doi: 10.1016/j.vaccine.2023.02.037. Epub 2023 Feb 18.
Neonatal Group B Streptococcal Infection in Australia: A Case-control Study. Marianne Yanni 1 2, Michael Stark 2 3, Laura Francis 4, Joshua R Francis 4 5, Mark McMillan 2 6, Rob Baird 7, Paul T Heath 8, Alex Gordon 1, James Riccardione 7, Angela Wilson 7, Rebecca Lee 4, Kathrina Chooi 6, Olivia-Paris Quinn 6, Helen S Marshall 2 3 6. Pediatr Infect Dis J. 2023 Mar 16. doi: 10.1097/INF.0000000000003881. Online ahead of print.
Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness. Simon R. Procter ,Bronner P. Gonçalves,Proma Paul,Jaya Chandna,Farah Seedat,Artemis Koukounari,Raymond Hutubessy,Caroline Trotter,Joy E. Lawn,Mark Jit. Published: March 14, 2023. https://doi.org/10.1371/journal.pmed.1004068.
Prevalence of Group B Streptococcus maternal colonization, serotype distribution, and antimicrobial resistance in Sub-Saharan Africa: A systematic review and meta-analysis. Fiseha Wadilo 1, Elifaged Hailemeskel 2, Kiya Kedir 3, Ziad El-Khatib 4, Phonix Constant Asogba 5, Tamrayehu Seyoum 6, Fongang Che Landis 7, Rawliegh Howe 8, Minyahil Tadesse Boltena 9. J Glob Antimicrob Resist. 2023 Mar;32:134-144. doi: 10.1016/j.jgar.2023.02.004. Epub 2023 Feb 20.
Using Dried Blood Spots for a Sero-Surveillance Study of Maternally Derived Antibody against Group B Streptococcus. Erick Auma 1 2, Tom Hall 2, Simran Chopra 3, Sam Bilton 4, Laxmee Ramkhelawon 2, Fahimah Amini 2, Anna Calvert 2, Gayatri Amirthalingam 5, Christine E Jones 2 6 7, Nick Andrews 5, Paul T Heath 2, Kirsty Le Doare 2 8 9. Vaccines (Basel). 2023 Feb 4;11(2):357. doi: 10.3390/vaccines11020357.
Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches. Absalon J, Simon R, Radley D, Giardina PC, Koury K, Jansen KU, Anderson AS. Hum Vaccin Immunother. 2022 Dec 31;18(1):2037350. doi: 10.1080/21645515.2022.2037350. Epub 2022 Mar 3. PMID: 35240933; PMCID: PMC9009955.
Simultaneous carriage of multiple serotypes of Group B Streptococcus: Systematic review and meta-analysis. Barro C, Salloum M, Lim S, Delputte P, Le Doare K. Vaccine. 2023 Jan 4;41(1):15-22. doi: 10.1016/j.vaccine.2022.11.024. Epub 2022 Nov 23.
Race and Ethnicity in Neonatal Group B Streptococcal Disease in England: 2016-2020. Collin SM, Demirjian A, Swann C, Lamagni T. Pediatrics. 2022 Aug 18:e2021056080. doi: 10.1542/peds.2021-056080. Epub ahead of print. PMID: 35979728.
Immediate birth for women between 34 and 37 weeks of gestation with prolonged preterm prelabour rupture of membranes and detection of vaginal or urine group B streptococcus: an economic evaluation. Dietz J, Plumb J, Banfield P, Soe A, Chehadah F, Chang-Douglass S, Rogers G. BJOG. 2022 Sep;129(10):1779-1789. doi: 10.1111/1471-0528.17119. Epub 2022 Mar 8. PMID: 35137528.
Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Bronner P. Gonçalves, Simon R. Procter et al.
The Lancet Global Health, 10, 6, 6 2022
Every Country, Every Family: Time to Act for Group B Streptococcal Disease Worldwide, Joy E Lawn, Jaya Chandna, Proma Paul, Mark Jit, Caroline Trotter, Philipp Lambach, Ajoke Sobanjo Ter-Meulen. Clinical Infectious Diseases, Volume 74, Issue Supplement_1, 15 January 2022, Pages S1–S4,
South African Children: A Matched Cohort Study of Neurodevelopmental Impairment in Survivors of Invasive Group B Streptococcus Disease Aged 5 to 8 Years. Lois M Harden, Shannon Leahy, Sanjay G Lala, Proma Paul, Jaya Chandna, Sarah Lowick, Sibongile Mbatha, Tamara Jaye, Barbara Laughton, Azra Ghoor, Pamela Sithole, Jacqueline Msayi, Ntombifuthi Kumalo, Tshepiso N Msibi, Shabir A Madhi, Joy E Lawn, Ziyaad Dangor. Clinical Infectious Diseases, Volume 74, Issue Supplement_1, 15 January 2022, Pages S5–S13,
South Indian Children’s Neurodevelopmental Outcomes After Group B Streptococcus Invasive Disease: A Matched-Cohort Study. Hima B John, Asha Arumugam, Mohana Priya, Nandhini Murugesan, Nandhini Rajendraprasad, Grace Rebekah, Proma Paul, Jaya Chandna, Joy E Lawn, Sridhar Santhanam
Clinical Infectious Diseases, Volume 74, Issue Supplement_1, 15 January 2022, Pages S24–S34
Emotional and Behavioral Outcomes in Childhood for Survivors of Invasive Group B Streptococcus Disease in Infancy: Findings From 5 Low- and Middle-Income Countries. Jaya Chandna, Wan-Hsin Liu, Ziyaad Dangor, Shannon Leahy, Santhanam Sridhar, Hima B John, Humberto Mucasse, Quique Bassat, Azucena Bardaji, Amina Abubakar, Carophine Nasambu, Charles R Newton, Clara Sánchez Yanotti, Romina Libster, Kate Milner, Proma Paul, Joy E Lawn, GBS Low and Middle income Collaborative Group for Long-term Outcomes group. Clinical Infectious Diseases, Volume 74, Issue Supplement_1, 15 January 2022, Pages S35–S43
Short- and Long-term Outcomes of Group B Streptococcus Invasive Disease in Mozambican Children: Results of a Matched Cohort and Retrospective Observational Study and Implications for Future Vaccine Introduction. Justina Bramugy, Humberto Mucasse, Sergio Massora, Pio Vitorino, Céline Aerts, Inacio Mandomando, Proma Paul, Jaya Chandna, Farah Seedat, Joy E Lawn, Azucena Bardají, Quique Bassat. Clinical Infectious Diseases, Volume 74, Issue Supplement_1, 15 January 2022, Pages S14–S23
Prematurity Modifies the Risk of Long-term Neurodevelopmental Impairments After Invasive Group B Streptococcus Infections During Infancy in Denmark and the Netherlands. Erzsébet Horváth-Puhó, Linde Snoek, Merel N van Kassel, Bronner P Gonçalves, Jaya Chandna, Simon R Procter, Diederik van de Beek, Brechje de Gier, Arie van der Ende, Henrik T Sørensen, Joy E Lawn, Merijn W Bijlsma, GBS Danish and Dutch Collaborative Group for Long-term Outcomes. Clinical Infectious Diseases, Volume 74, Issue Supplement_1, 15 January 2022, Pages S44–S53
Sex Differences in Long-term Outcomes After Group B Streptococcal Infections During Infancy in Denmark and the Netherlands: National Cohort Studies of Neurodevelopmental Impairments and Mortality. Merel N van Kassel, Bronner P Gonçalves, Linde Snoek, Henrik T Sørensen, Merijn W Bijlsma, Joy E Lawn, Erzsébet Horváth-Puhó, GBS Danish and Dutch Collaborative Group for Long-Term Outcomes. Clinical Infectious Diseases, Volume 74, Issue Supplement_1, 15 January 2022, Pages S54–S63,
Quantifying the Acute Care Costs of Neonatal Bacterial Sepsis and Meningitis in Mozambique and South Africa. Céline Aerts, Shannon Leahy, Humberto Mucasse, Sanjay Lala, Justina Bramugy, Cally J Tann, Shabir A Madhi, Azucena Bardají, Quique Bassat, Ziyaad Dangor, Joy E Lawn, Mark Jit, Simon R Procter. Clinical Infectious Diseases, Volume 74, Issue Supplement_1, 15 January 2022, Pages S64–S69
A Financial and Global Demand Analysis to Inform Decisions for Funding and Clinical Development of Group B Streptococcus Vaccines for Pregnant Women. Stefano Malvolti, Clint Pecenka, Carsten F Mantel, Melissa Malhame, Philipp Lambach. Clinical Infectious Diseases, Volume 74, Issue Supplement_1, 15 January 2022, Pages S70–S79
Stakeholder Perceptions About Group B Streptococcus Disease and Potential for Maternal Vaccination in Low- and Middle-Income Countries. Carsten Mantel, Thomas Cherian, Melissa Ko, Stefano Malvolti, Elizabeth Mason, Michelle Giles, Philipp Lambach. Clinical Infectious Diseases, Volume 74, Issue Supplement_1, 15 January 2022, Pages S80–S87
Assessing the added value of group B Streptococcus maternal immunisation in preventing maternal infection and fetal harm: population surveillance study. Lamagni T, Wloch C, Broughton K, Collin SM, Chalker V, Coelho J, Ladhani SN, Brown CS, Shetty N, Johnson AP. BJOG. 2022 Jan;129(2):233-240. doi: 10.1111/1471-0528.16852. Epub 2021 Aug 17. PMID: 34324252
Laboratory surveillance of pyogenic and non-pyrogenic streptococcal bacteraemia in England: 2020 Public Health England (serial online) Health Protection Report. 15(19): Bacteraemia. Nov 2021.
Intrapartum Group B Streptococcal Prophylaxis and Childhood Allergic Disorders. Dhudasia MB, Spergel JM, Puopolo KM, Koebnick C, Bryan M, Grundmeier RW, Gerber JS, Lorch SA, Quarshie WO, Zaoutis T, Mukhopadhyay S. Pediatrics. 2021 Apr 8:e2020012187. doi: 10.1542/peds.2020-012187.
Group B Streptococcal disease in England (1998 – 2017): a population based observational study. Kadambari S, Trotter CL, Heath PT, Goldacre MJ, Pollard AJ, Goldacre R. Clin Infect Dis. 2020 Sep 29:ciaa1485. doi: 10.1093/cid/ciaa1485. Epub ahead of print. PMID: 32989454.
Preventing early-onset group B streptococcal sepsis: clinical risk factor-based screening or culture-based screening? Lee J, Naiduvaje K, Chew KL, Charan N, Chan YH, Lin RT, Yong EL. Singapore Med J. 2021 Jan;62(1):34-38. doi: 10.11622/smedj.2019155.
Oral probiotics to reduce vaginal group B streptococcal colonization in late pregnancy. Alex Farr, Valentina Sustr, Herbert Kiss, Ingo Rosicky, Alexandra Graf, Athanasios Makristathis, Philipp Foessleitner, Ljubomir Petricevic. Sci Rep. 2020 Nov 12;10(1):19745. doi: 10.1038/s41598-020-76896-4. PMID: 33184437 PMCID: PMC7665007
Impact of late-onset group B streptococcus infection on families: An observational study. Grace Raybould, Jane Plumb, Alison Stanley, Kate F Walker. Eur J Obstet Gynecol Reprod Biol. 2020 Nov 1;256:51-56. doi: 10.1016/j.ejogrb.2020.10.022. PMID: 33166798 DOI: 10.1016/j.ejogrb.2020.10.022
Risk-based screening and intrapartum group B streptococcus polymerase chain reaction results reduce use of antibiotics during labour. Louise Rottbøll Rosenberg, Anne Katrine Normann, Birgitte Henriksen, Jesper Fenger-Gron, Jens Kjølseth Møller, Mohammed Rohi Khalil. Dan Med J. 2020 Oct 20;67(11):A06200460.
Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates. Bianchi-Jassir F, Paul P, To KN, Carreras-Abad C, Seale AC, Jauneikaite E, Madhi SA, Russell NJ, Hall J, Madrid L, Bassat Q, Kwatra G, Le Doare K, Lawn JE. Vaccine. 2020 Oct 7;38(43):6682-6694. doi: 10.1016/j.vaccine.2020.08.052. Epub 2020 Sep 2. PMID: 32888741
Group B Streptococcal disease in England (1998 – 2017): a population based observational study. Kadambari S, Trotter CL, Heath PT, Goldacre MJ, Pollard AJ, Goldacre R. Clin Infect Dis. 2020 Sep 29:ciaa1485. doi: 10.1093/cid/ciaa1485. PMID: 32989454
Uncovering infant group B streptococcal (GBS) disease clusters in the UK and Ireland through genomic analysis: a population-based epidemiological study. Collin SM, Groves N, O’Sullivan C, Jauneikaite E, Patel D, Cunney R, Meehan M, Reynolds A, Smith A, Lindsay D, Doherty L, Davies E, Chalker V, Lamb P, Afshar B, Balasegaram S, Coelho J, Ready D, Brown CS, Efstratiou A, Le Doare K, Sriskandan S, Heath PT, Lamagni T. Clin Infect Dis. 2020 Aug 7:ciaa1087. doi: 10.1093/cid/ciaa1087. Online ahead of print. PMID: 32766850
To screen or not to screen women for Group B Streptococcus (Streptococcus agalactiae) to prevent early onset sepsis in newborns: recent advances in the unresolved debate. Rao GG, Khanna P. Ther Adv Infect Dis. 2020 Jul 13;7:2049936120942424. doi: 10.1177/2049936120942424. eCollection 2020 Jan-Dec. PMID: 32704370
The global meningitis genome partnership. Rodgers E, Bentley SD, Borrow R, Bratcher HB, Brisse S, Brueggemann AB, Caugant DA, Findlow J, Fox L, Glennie L, Harrison LH, Harrison OB, Heyderman RS, van Rensburg MJ, Jolley KA, Kwambana-Adams B, Ladhani S, LaForce M, Levin M, Lucidarme J, MacAlasdair N, Maclennan J, Maiden MCJ, Maynard-Smith L, Muzzi A, Oster P, Rodrigues CMC, Ronveaux O, Serino L, Smith V, van der Ende A, Vázquez J, Wang X, Yezli S, Stuart JM. J Infect. 2020 Oct;81(4):510-520. doi: 10.1016/j.jinf.2020.06.064. Epub 2020 Jun 29. PMID: 32615197
Group B streptococcal disease in the mother and newborn – A review. Steer PJ, Russell AB, Kochhar S, Cox P, Plumb J, Gopal Rao G. Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:526-533. doi: 10.1016/j.ejogrb.2020.06.024. Epub 2020 Jun 15. PMID: 32586597
Invasive Group B Streptococcus Infections in Adults, England, 2015-2016. Collin SM, Shetty N, Lamagni T. Emerg Infect Dis. 2020 Jun;26(6):1174-1181. doi: 10.3201/eid2606.191141. PMID: 32441619; PMCID: PMC7258460.
Initial findings from a novel population-based child mortality surveillance approach: a descriptive study. Taylor AW, Blau DM, Bassat Q, Onyango D, Kotloff KL, Arifeen SE, Mandomando I, Chawana R, Baillie VL, Akelo V, Tapia MD, Salzberg NT, Keita AM, Morris T, Nair S, Assefa N, Seale AC, Scott JAG, Kaiser R, Jambai A, Barr BAT, Gurley ES, Ordi J, Zaki SR, Sow SO, Islam F, Rahman A, Dowell SF, Koplan JP, Raghunathan PL, Madhi SA, Breiman RF; CHAMPS Consortium. Lancet Glob Health. 2020 Jul;8(7):e909-e919. doi: 10.1016/S2214-109X(20)30205-9. PMID: 32562647
The enemy within. Plumb J. Midwives. Epub 2020 July.
Invasive Group B Streptococcus Infections in Adults, England, 2015-2016. Emerg Infect Dis. 2020 Jun;26(6):1174-1181. doi: 10.3201/eid2606.191141.PMID: 32441619
Group B streptococcal disease in the mother and newborn – A review. Steer PJ, Russell AB, Kochhar S, Cox P, Plumb J, Gopal Rao G.
Eur J Obstet Gynecol Reprod Biol. 2020 Jun 15:S0301-2115(20)30391-2. doi: 10.1016/j.ejogrb.2020.06.024. Online ahead of print. PMID: 32586597
Association Between Maternal Obesity and Group B Streptococcus Colonization in a National U.S. Cohort. Venkatesh KK, Vladutiu CJ, Strauss RA, Thorp JM, Stringer JSA, Stamilio DM, Hughes BL, Dotters-Katz S. J Womens Health (Larchmt). 2020 May 4. doi: 10.1089/jwh.2019.8139.
Is Group B Streptococcus Colonization Associated with Maternal Peripartum Infection in an Era of Routine Prophylaxis? Am J Perinatol. 2020 May 23. doi: 10.1055/s-0040-1709666. Online ahead of print. PMID: 32446262
Screening-based and Risk-based Strategy for the Prevention of Early-onset Group B Streptococcus/Non-group B Streptococcus Sepsis in the Neonate: A Systematic Review and Meta-analysis. Pediatr Infect Dis J. 2020 May 12. doi: 10.1097/INF.0000000000002674. Online ahead of print. PMID: 32404781
Universal testing for group B streptococcus during pregnancy: need for a randomised trial. Walker KF, Morris E, Plumb J, Gray J, Thornton JG, Daniels J. BJOG. 2020 May;127(6):693. doi: 10.1111/1471-0528.16116.
An obstetrician’s dilemma – a parody. M A Turrentine. 2020 May;127(6):692. doi: 10.1111/1471-0528.16097. Epub 2020 Feb 9.
Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies. Stoll BJ, Puopolo KM, Hansen NI, Sánchez PJ, Bell EF, Carlo WA, Cotten CM, D’Angio CT, Kazzi SNJ, Poindexter BB, Van Meurs KP, Hale EC, Collins MV, Das A, Baker CJ, Wyckoff MH, Yoder BA, Watterberg KL, Walsh MC, Devaskar U, Laptook AR, Sokol GM, Schrag SJ, Higgins RD; and the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. JAMA Pediatr. 2020 May 4:e200593. doi: 10.1001/jamapediatrics.2020.0593.
A Vaccine Against Group B Streptococcus: Recent Advances. Infect Drug Resist. 2020 Apr 29;13:1263-1272. doi: 10.2147/IDR.S203454. eCollection 2020.PMID: 32425562
Risk-based maternal group B streptococcus screening strategy is compatible with neonatal early onset sepsis calculator implementation. Clin Exp Pediatr. 2020 Apr 16. doi: 10.3345/cep.2020.00094. Online ahead of print.PMID: 32299178
Preventing Early-Onset Group B Streptococcus neonatal infection and reducing antibiotic exposure using a rapid PCR test in term prelabour rupture of membranes. Wang M, Keighley C, Watts M, Plymoth M, McGee TM. Aust N Z J Obstet Gynaecol. 2020 Apr 14. doi: 10.1111/ajo.13159.
Cost Effectiveness of Latest Recommendations for Group B Streptococci Screening in the United States. Williams M, Zantow E, Turrentine M. Obstet Gynecol. 2020 Apr;135(4):789-798. doi: 10.1097/AOG.0000000000003649.
The Epidemiology of Invasive Group B Streptococcus in Denmark From 2005 to 2018. Front Public Health. 2020 Mar 10;8:40. doi: 10.3389/fpubh.2020.00040. eCollection 2020.PMID: 32211361
Safety and immunogenicity of fully liquid and lyophilized formulations of an investigational trivalent group B streptococcus vaccine in healthy non-pregnant women: Results from a randomized comparative phase II trial. Beran J, Leroux-Roels G, Van Damme P, de Hoon J, Vandermeulen C, Al-Ibrahim M, Johnson C, Peterson J, Baker S, Seidl C, Dreisbach A, Karsten A, Corsaro B, Henry O, Lattanzi M, Bebia Z. Vaccine. 2020 Apr 3;38(16):3227-3234. doi: 10.1016/j.vaccine.2020.02.085. Epub 2020 Mar 10.
Urine dipstick for predicting intrapartum recto-vaginal colonisation by group B streptococci. Khalil MR, Uldbjerg N, Thorsen PB, Møller JK. Dan Med J. 2020 Feb;67(2). pii: A08190466.
Universal testing for group B streptococcus during pregnancy: need for a randomised trial. Walker KF, Morris E, Plumb J, Gray J, Thornton JG, Daniels J. BJOG. 2020 Jan 30. doi: 10.1111/1471-0528.16116.
Disturbing the neonatal microbiome is a small price to pay for preventing early-onset neonatal group B streptococcus disease: AGAINST: Against relying on antibiotics to prevent early-onset neonatal group B streptococcus disease. Aronoff DM, Blaser MJ. BJOG. 2020 Jan;127(2):229. doi: 10.1111/1471-0528.15988.
Intrapartum beta-lactam antibiotics for preventing group B streptococcal early-onset disease: can we abandon the concept of ‘inadequate’ intrapartum antibiotic prophylaxis? Berardi A, Spada C, Vaccina E, Boncompagni A, Bedetti L, Lucaccioni L. Expert Rev Anti Infect Ther. 2020 Jan;18(1):37-46. doi: 10.1080/14787210.2020.1697233.
Disturbing the neonatal microbiome is a small price to pay for preventing early-onset neonatal group B streptococcus disease: FOR: Intrapartum antibiotic prophylaxis – offering opportunities or creating difficulties? Turrentine MA. BJOG. 2020 Jan;127(2):228. doi: 10.1111/1471-0528.15989. Epub 2019 Nov 1. PMID: 3167722
Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis. Husain S, Allotey J, Drymoussi Z, Wilks M, Fernandez-Felix BM, Whiley A, Dodds J, Thangaratinam S, McCourt C, Prosdocimi EM, Wade WG, de Tejada BM, Zamora J, Khan K, Millar M. BJOG. 2020 Jan;127(2):275-284. doi: 10.1111/1471-0528.15675
Universal screening versus risk‐based protocols for antibiotic prophylaxis during childbirth to prevent early‐onset Group B streptococcal disease: a systematic review and meta‐analysis. GF Hasperhoven, S Al‐Nasiry, V Bekker, E Villamor, BWW Kramer. BJOG. 2020 Jan 8. doi: 10.1111/1471-0528.16085.
Group B Streptococcus detection in pregnant women: comparison of qPCR assay, culture, and the Xpert GBS rapid test. Vieira LL, Perez AV, Machado MM, Kayser ML, Vettori DV, Alegretti AP, Ferreira CF, Vettorazzi J, Valério EG. BMC Pregnancy Childbirth. 2019 Dec 30;19(1):532. doi: 10.1186/s12884-019-2681-0.
Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study. Carreras-Abad C, Cochet M, Hall T, Ramkhelawon L, Khalil A, Peregrine E, Vinayakarao L, Sivarajan S, Hamid R, Planche T, Sheridan E, Winchester S, Plumb J, Djennad A, Andrews N, Le Doare K, Heath P. Health Technol Assess. 2019 Dec;23(67):1-40. doi: 10.3310/hta23670.
Evaluation of women’s worries in different strategies for the prevention of early onset group B streptococcal disease in neonates.
Kolkman DGE, Martin L, Jans S, Wouters MGAJ, van Dommelen P, Fleuren MAH, de Groot CJM, Rijnders MEB. Midwifery. 2019 Dec 28;86:102623. doi: 10.1016/j.midw.2019.102623.
Adherence to three different strategies to prevent early onset GBS infection in newborns. Kolkman DGE, Rijnders MEB, Wouters MGAJ, Dommelen PV, de Groot CJM, Fleuren MAH. Women Birth. 2019 Dec 21. pii: S1871-5192(19)30367-1. doi: 10.1016/j.wombi.2019.12.004.
Stillbirth Associated With Infection in a Diverse U.S. Cohort. Page JM, Bardsley T, Thorsten V, Allshouse AA, Varner MW, Debbink MP, Dudley DJ, Saade GR, Goldenberg RL, Stoll B, Hogue CJ, Bukowski R, Conway D, Reddy UM, Silver RM. Obstet Gynecol. 2019 Dec;134(6):1187-1196. doi: 10.1097/AOG.0000000000003515.
Preventing early-onset group B streptococcal sepsis: clinical risk factor-based screening or culture-based screening? Lee J, Naiduvaje K, Chew KL, Charan N, Chan YH, Lin RT, Yong EL. Singapore Med J. 2019 Dec 2. doi: 10.11622/smedj.2019155.
Hospital clusters of invasive Group B Streptococcal disease: A systematic review. Collin SM, Lamb P, Jauneikaite E, Le Doare K, Creti R, Berardi A, Heath PT, Sriskandan S, Lamagni T. J Infect. 2019 Dec;79(6):521-527. doi: 10.1016/j.jinf.2019.11.008.
Clinical features and outcomes of community-acquired late-onset sepsis: Focusing on group B Streptococcus and Escherichia coli. Yun KW, Park SH, Cho EY, Lee H. Pediatr Int. 2019 Dec;61(12):1210-1215. doi: 10.1111/ped.14012.
Compliance with screening for and recommended management of maternal group B streptococcus carriage in pregnancy. Moorhead R, Daley AJ, Lee LY, Gorelik A, Garland SM. Aust N Z J Obstet Gynaecol. 2019 Dec;59(6):837-842. doi: 10.1111/ajo.12977.
Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: a systematic review and meta-analysis in line with the STROBE-NI reporting guidelines. Okomo U, Akpalu ENK, Le Doare K, Roca A, Cousens S, Jarde A, Sharland M, Kampmann B, Lawn JE. Lancet Infect Dis. 2019 Nov;19(11):1219-1234. doi: 10.1016/S1473-3099(19)30414-1.
Laboratory surveillance of pyogenic and non-pyrogenic streptococcal bacteraemia in England: 2019 Public Health England (serial online) Health Protection Report. 14(24): Bacteraemia.
Variations in antibiotic susceptibility of group B Streptococcus in Japanese women: A long-term population-based cohort study. Gomi Y, Wang L, Matsushima H, Kawabe A, Kikugawa A, Takagi A, Kuromaki K. Taiwan J Obstet Gynecol. 2019 Nov;58(6):805-807. doi: 10.1016/j.tjog.2019.09.014.
Epidemiology and complications of late-onset sepsis: an Italian area-based study. Berardi A, Sforza F, Baroni L, Spada C, Ambretti S, Biasucci G, Bolognesi S, Capretti M, Carretto E, Ciccia M, Lanari M, Pedna MF, Rizzo V, Venturelli C, Tzialla C, Lucaccioni L, Reggiani MLB. PLoS One. 2019 Nov 22;14(11):e0225407. doi: 10.1371/journal.pone.0225407. eCollection 2019.
Early-onset sepsis: can we screen fewer babies safely? Eason J, Ward H, Danko O, Richardson K, Vaitkute R, McKeon-Carter R. Arch Dis Child. 2019 Nov 2. pii: archdischild-2019-317047. doi: 10.1136/archdischild-2019-317047.
Antibiotic Use Without Indication During Delivery Hospitalizations in the United States. Andrikopoulou M, Huang Y, Duffy CR, Stern-Ascher CN, Wright JD, Goffman D, DʼAlton ME, Friedman AM. Obstet Gynecol. 2019 Oct;134(4):718-725. doi: 10.1097/AOG.0000000000003485.
Vaginal-perineal cultures for detecting group B streptococci and extended spectrum β-lactamase producing bacteria in pregnancy. Huang DJ, Hösli I, Tschudin-Sutter S, Pfister T, Granado C, Müller-Borer D, Schötzau A, Frei R, Dangel M, Huhn EA, Widmer A, Vuichard-Gysin D. Eur J Obstet Gynecol Reprod Biol. 2019 Oct;241:24-29. doi: 10.1016/j.ejogrb.2019.07.024
Pregnant women’s knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines. Giles ML, Buttery J, Davey MA, Wallace E. Vaccine. 2019 Oct 16;37(44):6743-6749. doi: 10.1016/j.vaccine.2019.08.084
Differential rates of group B streptococcus (GBS) colonisation in pregnant women in a racially diverse area of London, UK: a cross-sectional study. Gopal Rao G, Hiles S, Bassett P, Lamagni T. BJOG. 2019 Oct;126(11):1347-1353. doi: 10.1111/1471-0528.15648
Epidemiological factors impact group B streptococcus carriage. Lao TT. BJOG. 2019 Oct;126(11):1353. doi: 10.1111/1471-0528.15871.
Severe Group A and Group B Streptococcus diseases at a Pediatric ICU: Are they still sensitive to the penicillins? Hon KL, Chow TC, Cheung TS, Lam WT, Hung LT, So KW, Ip M, Qian SY. Curr Clin Pharmacol. 2019 Sep 26. doi: 10.2174/1574884714666190926124714.
Clinical and Microbiological Characteristics of Group B Streptococcus from Pregnant Women and Diseased Infants in Intrapartum Antibiotic Prophylaxis Era in Taiwan. Lee CC, Hsu JF, Prasad Janapatla R, Chen CL, Zhou YL, Lien R, Chiu CH. Sci Rep. 2019 Sep 19;9(1):13525. doi: 10.1038/s41598-019-49977-2.
Recurrence of group B streptococcal meningitis. Butler V, Pejoan H, Blot N. Arch Pediatr. 2019 Sep;26(6):374-376. doi: 10.1016/j.arcped.2019.08.003
Group B streptococcus is the most common pathogen for septic arthritis with unique clinical characteristics: data from 12 years retrospective cohort study. Ruksasakul R, Narongroeknawin P, Assavatanabodee P, Chaiamnuay S. BMC Rheumatol. 2019 Sep 16;3:38. doi: 10.1186/s41927-019-0084-5. eCollection 2019.
Prevalence and treatment of group B streptococcus colonization based on risk factors versus intrapartum culture screening. Johansen NR, Kjærbye-Thygesen A, Jønsson S, Westh H, Nilas L, Rørbye C. Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:178-181. doi: 10.1016/j.ejogrb.2019.06.037
Risk of invasive bacterial infections by week of age in infants: prospective national surveillance, England, 2010-2017. Ladhani SN, Henderson KL, Muller-Pebody B, Ramsay ME, Riordan A. Arch Dis Child. 2019 Sep;104(9):874-878. doi: 10.1136/archdischild-2018-316191.
Safety and immunogenicity of a second dose of an investigational maternal trivalent Group B streptococcus vaccine in non-pregnant women 4-6 years after a first dose: results from a phase 2 trial. Leroux-Roels G, Bebia Z, Maes C, Aerssens A, De Boever F, Grassano L, Buffi G, Margarit I, Karsten A, Cho S, Slobod K, Corsaro B, Henry O. Clin Infect Dis. 2019 Aug 8. pii: ciz737. doi: 10.1093/cid/ciz737.
Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions. Seale AC, Baker CJ, Berkley JA, Madhi SA, Ordi J, Saha SK, Schrag SJ, Sobanjo-Ter Meulen A, Vekemans J. Vaccine. 2019 Aug 14;37(35):4877-4885. doi: 10.1016/j.vaccine.2019.07.012.
Prevention of Group B Streptococcal Early-Onset Disease in Newborns. Pediatrics. Am Acad Ped. 2019 Aug;144(2). pii: e20191882. doi: 10.1542/peds.2019-1882.
Detection of group B Streptococcus during antenatal screening in Western Australia: a comparison of culture and molecular methods. Furfaro LL, Chang BJ, Payne MS. J Appl Microbiol. 2019 Aug;127(2):598-604. doi: 10.1111/jam.14331.
Management of Infants at Risk for Group B Streptococcal Disease. Puopolo KM, Lynfield R, Cummings JJ; COMMITTEE ON FETUS AND NEWBORN; COMMITTEE ON INFECTIOUS DISEASES. Pediatrics. 2019 Aug;144(2). pii: e20191881. doi: 10.1542/peds.2019-1881. Epub 2019 Jul 8. Review. Erratum in: Pediatrics. 2019 Oct;144(4)
Effect of intrapartum antibiotics on the intestinal microbiota of infants: a systematic review. Zimmermann P, Curtis N. Arch Dis Child Fetal Neonatal Ed. 2019 Jul 11. pii: fetalneonatal-2018-316659. doi: 10.1136/archdischild-2018-316659.
Intrapartum antibiotics for prolonged rupture of membranes at term to prevent Group B Streptococcal sepsis. Geethanath RM, Ahmed I, Abu-Harb M, Onwuneme C, McGarry K, Hinshaw K. J Obstet Gynaecol. 2019 Jul;39(5):619-622. doi: 10.1080/01443615.2018.1550474.
Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 782. Obstet Gynecol. 2019 Jul;134(1):e19-e40. doi: 10.1097/AOG.0000000000003334.
Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion Summary, Number 782. Obstet Gynecol. 2019 Jul;134(1):206-210. doi: 10.1097/AOG.0000000000003335.
Universal versus Risk-Based Management of Unknown Group B Streptococcus Status at Term. Jones DM, Haikal SO, Whitham MD, Howard DL. AJP Rep. 2019 Jul;9(3):e315-e322. doi: 10.1055/s-0039-1695744.
Suggested Modifications To Improve the Sensitivity and Specificity of the 2010 CDC-Recommended Routine Streptococcus agalactiae Screening Culture for Pregnant Women. Salimnia H, Robinson-Dunn B, Gundel A, Campbell A, Mitchell R, Taylor M, Fairfax MR. J Clin Microbiol. 2019 Jul 26;57(8). pii: e00446-19. doi: 10.1128/JCM.00446-19.
Risk factors for group B streptococcus early-onset disease: an Italian, area-based, case-control study. Berardi A, Spada C, Creti R, Ambretti S, Chiarabini R, Barozzi A, Pagano R, Sarti M, Pedna MF, Fornaciari S, Azzalli M, Dodi I, Bacchi Reggiani ML, Lanzoni A, Vaccina E, Iughetti L, Lucaccioni L. J Matern Fetal Neonatal Med. 2019 Jul 17:1-7. doi: 10.1080/14767058.2019.1628943
Intrapartum PCR-assay for detection of Group B Streptococci (GBS). Helmig RB, Gertsen JB. Eur J Obstet Gynecol Reprod Biol X. 2019 Jun 27;4:100081. doi: 10.1016/j.eurox.2019.100081.
Group B Streptococcus: Trials and Tribulations. Davies HG, Carreras-Abad C, Le Doare K, Heath PT. Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S72-S76. doi: 10.1097/INF.0000000000002328.
The association between breastmilk group B Streptococcal capsular antibody levels and late-onset disease in young infants. Dangor Z, Khan M, Kwatra G, Izu A, Nakwa F, Ramdin T, Fredericks J, Lala SG, Madhi SA. Clin Infect Dis. 2019 May 6. pii: ciz360. doi: 10.1093/cid/ciz360.
Serocorrelates of protection against infant group B streptococcus disease. Le Doare K, Kampmann B, Vekemans J, Heath PT, Goldblatt D, Nahm MH, Baker C, Edwards MS, Kwatra G, Andrews N, Madhi SA, Ter Meulen AS, Anderson AS, Corsaro B, Fischer P, Gorringe A. Lancet Infect Dis. 2019 May;19(5):e162-e171. doi: 10.1016/S1473-3099(18)30659-5.
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations. Vekemans J, Crofts J, Baker CJ, Goldblatt D, Heath PT, Madhi SA, Le Doare K, Andrews N, Pollard AJ, Saha SK, Schrag SJ, Smith PG, Kaslow DC. Vaccine. 2019 May 27;37(24):3190-3198. doi: 10.1016/j.vaccine.2019.04.039
Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands. de Gier B, van Kassel MN, Sanders EAM, van de Beek D, Hahné SJM, van der Ende A, Bijlsma MW. PLoS One. 2019 May 9;14(5):e0216749. doi: 10.1371/journal.pone.0216749.
Group B Streptococcus early-onset disease and observation of well-appearing newborns. Berardi A, Spada C, Reggiani MLB, Creti R, Baroni L, Capretti MG, Ciccia M, Fiorini V, Gambini L, Gargano G, Papa I, Piccinini G, Rizzo V, Sandri F, Lucaccioni L; GBS Prevention Working Group of Emilia-Romagna. PLoS One. 2019 Mar 20;14(3):e0212784. doi: 10.1371/journal.pone.0212784.
Preventing early-onset group B streptococcal sepsis: is there a role for rescreening near term? Mirsky R, Carpenter DM, Postlethwaite DA, Regenstein AC. J Matern Fetal Neonatal Med. 2019 Mar 19:1-7. doi: 10.1080/14767058.2019.1586874.
Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance. Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, Lynfield R, Vagnone PS, Burzlaff K, Spina NL, Dufort EM, Schaffner W, Thomas AR, Farley MM, Jain JH, Pondo T, McGee L, Beall BW, Schrag SJ. JAMA Pediatr. 2019 Mar 1;173(3):224-233. doi: 10.1001/jamapediatrics.2018.4826. Erratum in: JAMA Pediatr. 2019 Mar 1;173(3):296.
Prevention of early-onset group B streptococcal disease: a pinch of probability is worth a pound of perhaps. Turrentine M. BJOG. 2019 Mar;126(4):513. doi: 10.1111/1471-0528.15550.
Differential rates of group B Streptococcus (GBS) colonisation in pregnant women in a racially diverse area of London, UK: a cross-sectional study. Rao GG, Hiles S, Bassett P, Lamagni T. BJOG. 2019 Feb 7. doi: 10.1111/1471-0528.15648.
Universal antenatal screening for group B streptococcus may cause more harm than good. Seedat F, Geppert J, Stinton C, Patterson J, Freeman K, Johnson SA, Fraser H, Brown CS, Uthman OA, Tan B, Robinson ER, McCarthy ND, Clarke A, Marshall J, Visintin C, Mackie A, Taylor-Phillips S. BMJ. 2019 Feb 20;364:l463. doi: 10.1136/bmj.l463
Serocorrelates of protection against infant group B streptococcus disease. Le Doare K, Kampmann B, Vekemans J, Heath PT, Goldblatt D, Nahm MH, Baker C, Edwards MS, Kwatra G, Andrews N, Madhi SA, Ter Meulen AS, Anderson AS, Corsaro B, Fischer P, Gorringe A. Lancet Infect Dis. 2019 Jan 22. pii: S1473-3099(18)30659-5. doi: 10.1016/S1473-3099(18)30659-5.
Prevalence of group B streptococcus colonization in Iranian pregnant women: A systematic review and meta-analysis. Hossein YektaKooshali M, Hamidi M, Mohammad Taghi Razavi Tousi S, Nikokar I. Int J Reprod Biomed (Yazd). 2019 Jan 28;16(12). pii: ijrm.v16i12.3679. doi: 10.18502/ijrm.v16i12.3679
Group B Streptococcus and legal liability. Plumb O. BJOG. 2019 Mar;126(4):512. doi: 10.1111/1471-0528.15531.
Uncertainties in screening and prevention of Group B Streptococcus disease. Le Doare K, Heath PT, Plumb J, Owen NA, Brocklehurst P, Chappell LC. Clin Infect Dis. 2018 Dec 17. doi: 10.1093/cid/ciy1069.
Group B streptococcal disease in UK and Irish infants younger than 90 days, 2014-15: a prospective surveillance study. O’Sullivan CP, Lamagni T, Patel D, Efstratiou A, Cunney R, Meehan M, Ladhani S, Reynolds AJ, Campbell R, Doherty L, Boyle M, Kapatai G, Chalker V, Lindsay D, Smith A, Davies E, Jones CE, Heath PT. Lancet Infect Dis. 2018 Nov 26. pii: S1473-3099(18)30555-3. doi: 10.1016/S1473-3099(18)30555-3.
Group B streptococcal disease: unmet needs in high-income countries. Schrag SJ. Lancet Infect Dis. 2018 Nov 26. pii: S1473-3099(18)30604-2. doi: 10.1016/S1473-3099(18)30604-2.
Laboratory surveillance of pyogenic and non-pyogenic streptococcal bacteraemia in England, Wales and Northern Ireland: 2017: Public Health England (serial online) Health Protection Report. 12(41): Bacteraemia. 16 Oct 2018.
The incidence, characteristics, management and outcomes of anaphylaxis in pregnancy: a population‐based descriptive study. S J McCall, K J Bunch, P Brocklehurst, R D’Arcy, K Hinshaw, J J Kurinczuk, D N Lucas, B Stenson, D J Tuffnell, M Knight. BJOG. 2018 Jul;125(8):965-971. doi: 10.1111/1471-0528.15041. Epub 2018 Jan 3.
Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study. Giorgakoudi, K., O’Sullivan, C., Heath, P., Ladhani, S., Lamagni, T., Ramsay, M., et al. (2018) Vaccine. ISSN: 0264-410X
Serial Clustering of Late Onset Group B Streptococcal Infections in the Neonatal Unit – a Genomic Re-Evaluation of Causality. Jauneikaite E, Kapatai G, Davies F, Gozar I, Coelho J, Bamford KB, Simone B, Begum L, Katiyo S, Patel B, Hoffman P, Lamagni T, Brannigan ET, Holmes A, Kadhani T, Galletly T, Martin K, Lyall H, Chow Y, Godambe S, Chalker V, Sriskandan S. Clin Infect Dis. 2018 Mar 2. doi: 10.1093/cid/ciy174.
Impacts of early-onset group B Strep infection – perspective from families. Stanley A, Plumb O, Betts C, Plumb J. Poster Presentation ISSAD, Feb 2018.
Clinical Characteristics and Risk Factors for Poor Outcome in Infants Less Than 90 Days of Age with Bacterial Meningitis in the United Kingdom and Ireland. Okike IO, Ladhani SN, Johnson AP, Henderson KL, Blackburn RM, Muller-Pebody B, Cafferkey M, Anthony M, Ninis N, Heath PT; for the neoMen Study Group. Pediatr Infect Dis J. 2018 Jan 29. doi: 10.1097/INF.0000000000001917.
Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation. McQuaid F, Jones C, Stevens Z, Meddaugh G, O’Sullivan C, Donaldson B, Hughes R, Ford C, Finn A, Faust SN, Gbesemete D, Bedford H, Hughes S, Varghese AS, Heath PT, Snape MD. Acta Obstet Gynecol Scand. 2018 Mar;97(3):330-340. doi: 10.1111/aogs.13288. Epub 2018 Jan 19.
Early-onset group B Streptococcus (EOGBS) infection subsequent to cessation of screening-based intrapartum prophylaxis: findings of an observational study in West London, K. Rao GG, Townsend J, Stevenson D, Nartey G, Hiles S, Bassett P, Lamagni T, Nicholl R. BMJ Open. 2017 Nov 19;7(11):e018795. doi: 10.1136/bmjopen-2017-018795.
Outcome of a screening programme for the prevention of neonatal invasive early-onset group B Streptococcus infection in a UK maternity unit: an observational study. Rao GG, Nartey G, McAree T, O’Reilly A, Hiles S, Lee T, Wallace S, Batura R, Khanna P, Abbas H, Tilsed C, Nicholl R, Lamagni T, Bassett P. BMJ Open 2017;7:e014634. doi:10.1136/bmjopen-2016-014634.
Group B Streptococcal (GBS) disease in UK and Irish infants younger than 90 days, 2014–2015. O’Sullivan C, Lamagni T, Efstratiou A, Boyle M, Meehan M, Reynolds A, Doherty L, Cunney R & Heath P. (2016). Archives of Disease in Childhood, 101(Suppl 1), p. 2. doi: 10.1136/archdischild-2016-310863.3.
Voluntary surveillance of pyogenic and non-pyogenic streptococcal bacteraemia in England, Wales and Northern Ireland: 2015 : Public Health England (serial online) Health Protection Report. 10(41): Bacteraemia. Nov 2016
Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare professionals. McQuaid F, Pask S, Locock L, Davis E, Stevens Z, Plumb J, Snape MD. Vaccine. 2016 Jul 25;34(34):4056-61.
Factors influencing women’s attitudes towards antenatal vaccines, group B Streptococcus and clinical trial participation in pregnancy: an online survey. McQuaid F, Jones C, Stevens Z, Plumb J, Hughes R, Bedford H, Voysey M, Heath PT, Snape MD. BMJ Open. 2016 Apr 20;6(4):e010790.
Status of vaccine research and development of vaccines for GBS. Heath PT. Vaccine. 2016 Mar 15. pii: S0264-410X(16)00290-5. doi: 10.1016/j.vaccine.2015.12.072.
RCOG Audit of current practice in preventing early-onset neonatal group B streptococcal disease in the UK. Second Report. RCOG. 2016.
Pyogenic and non-pyogenic streptococcal bacteraemia (EWNI, 2014): Public Health England (serial online) 2015 Health Protection Report. 9(41): Bacteraemia.
Severe sepsis in women with group B Streptococcus in pregnancy: an exploratory UK national case-control study. Kalin A, Acosta C, Kurinczuk JJ, Brocklehurst P, Knight M. BMJ Open. 2015 Oct 8;5(10):e007976.
Group B Strep: where we are and where we’re heading. Trowman C, Steer P, Plumb J. MIDIRS Midwifery Digest, Vol 25, N02, June 2015, pp 161-164. Original article © MIDIRS 2015.
More needs to be done to prevent Group B strep infection in the UK. McQuaid F, Plumb J. BJM. Vol 23, No 6. 418-23. Published Online: June 04, 2015
RCOG Audit of current practice in preventing early-onset neonatal group B streptococcal disease in the UK. First Report. RCOG. 2015.
Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance. Okike IO, Johnson AP, Henderson KL, Blackburn RM, Muller-Pebody B, Ladhani SN, Anthony M, Ninis N, Heath PT; neoMen Study Group. Clin Infect Dis. 2014 Nov 15;59(10):e150-7. doi: 10.1093/cid/ciu514. Epub 2014 Jul 4.
Pyogenic and non-pyogenic streptococcal bacteraemia (EWNI, 2013): Public Health England (serial online) 2014 Health Protection Report. 8(44): Bacteraemia.
Prevention of early-onset Group B Streptococcal disease – the Northern Ireland experience. Eastwood K, Craig S, Sidhu H, Boyle M, Gannon C, Ong G, Lupari M, Craven A, Magowan S, Ashe R. BJOG. 2014 May 23.
Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study. Okike IO, Ribeiro S, Ramsay ME, Heath PT, Sharland M, Ladhani SN. Lancet Infect Dis. 2014 Apr;14(4):301-7. doi: 10.1016/S1473-3099(13)70332-3. Epub 2014 Feb 7.
Attitudes towards vaccination against group B streptococcus in pregnancy. McQuaid F, Jones C, Stevens Z, Plumb J, Hughes R, Bedford H, Heath PT, Snape MD. Arch Dis Child. 19 December 2013
Voluntary surveillance of pyogenic and non-pyogenic streptococcal bacteraemia in England, Wales and Northern Ireland: 2012 Public Health England (serial online) 2013 Health Protection Report. 7(46): Bacteraemia
Professionals respond to GBS article. Stewart M, Scamell M, McFarlane A / Plumb J, Clayton G. The Practising Midwife Oct 2013.
Childhood meningitis in the conjugate vaccine era: a prospective cohort study. Sadarangani M, Willis L, Kadambari S, Gormley S, Young Z, Beckley R, Gantlett K, Orf K, Blakey S, Martin NG, Kelly DF, Heath PT, Nadel S, Pollard AJ. Arch Dis Child. 2014 Sep 25. pii: archdischild-2014-306813. doi: 10.1136/archdischild-2014-306813.
Emerging Trends in the Epidemiology of Invasive Group B Streptococcal Disease in England and Wales,1991-2010. Lamagni TL et al. Clin Infect Dis. (2013) 57 (5):682-688.doi: 10.1093/cid/cit337 July 11, 2013
Group B streptococcus infection: risk and prevention Plumb, J. Clayton, G. The Practising Midwife Jul 2013
Screening will save newborn lives: a case for the introduction of routine screening for GBS late in pregnancy. Plumb J. GBSS. June 2013
GBS public awareness, advocacy, and prevention–what’s working, what’s not and why we need a maternal GBS vaccine. Burns G, Plumb J. Vaccine. 2013 Aug 28;31 Suppl 4:D58-65. doi: 10.1016/j.vaccine.2013.02.039.
Pyogenic and non-pyogenic streptococcal bacteraemia, England, Wales and Northern Ireland: 2011 Health Protection Report 2012; 6(46): Bacteraemia
Antenatal screening for group B streptococcus. Senior K. Lancet Infect Dis. 2012 Aug;12(8):589-90.
Screening will save newborn lives: a case for the introduction of routine screening for GBS in late pregnancy.Plumb J. GBSS. Jul 2012.
Feasibility of using microbiology diagnostic tests of moderate or high complexity at the point – of – care in a delivery suite. Gray JW, Milner PJ, Edwards EH, Daniels JP, Khan KS. J Obstet Gynaecol. 2012 Jul;32(5):458-60.
Non-culture detection of Streptococcus agalactiae (Lancefield group B Streptococcus) in clinical samples by real-time PCR. de Zoysa A, Edwards K, Gharbia S, Underwood A, Charlett A, Efstratiou A. Health Protection Agency, London, UK. J Med Microbiol. 2012 Jun 26.
Early onset group B streptococcus sepsis: guidelines review. Martin A, Vergnano S, Heath P, Anthony M, Kennea N, Watts T, Embleton N, Collinson A. Journal of Infection Prevention. May 2012 vol. 13 no. 3 75-78
Streptococcus B in pregnancy: to screen or not to screen? GBSS Medical Panel. BMJ April 2012
Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Karen M Edmond, Christina Kortsalioudaki, Susana Scott, Stephanie J Schrag, Anita K M Zaidi, Simon Cousens, Paul T Heath. 2012 Jan. The Lancet
Pyogenic and non-pyogenic streptococcal bacteraemia, England, Wales and Northern Ireland: 2010 Health Protection Report 2011; 5(46): Bacteraemia
Group B Streptococcal infection in infants Thakkar R. GP. Aug 2011
An update on vaccination against group B streptococcus Heath PT. Expert Rev Vaccines. 2011 May;10(5):685-94
Myth: Group B streptococcal infection in pregnancy: Comprehended and conquered Steer PJ, Plumb J. Seminars in Fetal & Neonatal Medicine. 13 April 2011.
Intrapartum tests for group B streptococcus: accuracy and acceptability of screening Daniels JP, Gray J, Pattison HM, Gray R, Hills RK, Khan KS; GBS Collaborative Group. BJOG. 2011 Jan;118(2):257-65. Epub 2010 Oct 13.
Cost-effectiveness of rapid tests and other existing strategies for screening and management of early-onset group B streptococcus during labour Kaambwa B, Bryan S, Gray J, Milner P, Daniels J, Khan K, Roberts T. BJOG. 2010 Dec; 117(13): 1616-27.
The contribution of infections to neonatal deaths in England and Wales Depani SJ, Ladhani S, Heath PT, Lamagni TL, Johnson AP, Pebody RG, Ramsay ME, Sharland M.Pediatr Infect Dis J. 2011 Apr;30(4):345-7.
Neonatal infections in England: the NeonIN surveillance network Vergnano S, Menson E, Kennea N, Embleton N, Russell AB, Watts T, Robinson MJ, Collinson A, Heath PT. Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F9-F14. Epub 2010 Sep 27.
Pyogenic and non-pyogenic streptococcal bacteraemia, England, Wales and Northern Ireland:2009 Health Protection Report 2010;4(46):bacteraemia.
Pyogenic and non-pyogenic streptococcal bacteraemias, England, Wales and Northern Ireland: 2008 November 2009;3(49):bacteraemia
Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness J Daniels, J Gray, H Pattison, T Roberts, E Edwards, P Milner, L Spicer, E King, RK Hills, R Gray, L Buckley, L Magill, N Elliman, B Kaambwa, S Bryan, R Howard, P Thompson and KS Khan. September 2009 Health Technol Assess 2009;13(42):1–178.
Group B streptococcal disease in infants: a case control study. May 2009. Arch Dis Child. Heath PT, Balfour G, Tighe H, Verlander NQ, Lamagni T, Efstratiou A.
Missed opportunities for preventing GBS infections May 2009. Arch Dis Child Fetal Neonatal Ed. Vergnano S, Embleton ND, Collinson A, Menson E, Bedford Russell AR, Heath PT.
Pyogenic and non-pyogenic Streptococcal bacteraemia, England, Wales & Northern Ireland: 2007 2008 November. HPR Vol 2 No 47.
The economic costs of Group B Streptococcus (GBS) disease: prospective cohort study of infants with GBS disease in England Nov 2008. Euro J Health Econ Schroeder EA, Petrou S, Balfour G, Edamma O, Heath PT; on behalf of the Health Protection Agency Group B Streptococcus Working Group.
Group B Strep: Testing Times. The Practising Midwife 2007 Dec; Vol 10 No 11 27-30. Plumb J, Holwell D, Clayton G.
Pyogenic and non-pyogenic Streptococcal bacteraemia, England, Wales & Northern Ireland: 2006 2007 November. HPR Vol 1 No 45.
Preventative strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses BMJ. 2007 Sep 29;335(7621):655. Epub 2007 Sep 11. Colbourn TE, Asseburg C, Bojke L, Philips Z, Welton NJ, Claxton K, Ades AE, Gilbert RE
Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses Health Technol Assess. 2007 Aug;11(29):1-226. Colbourn T, Asseburg C, Bojke L, Philips Z, Claxton K, Ades AE, Gilbert RE.
Pyogenic and non-pyogenic streptococcal bacteraemia, England, Wales and Northern Ireland: 2005. Commun Dis Rep Wkly 2006;16(46): Bacteraemia,
Water Birth for Women with GBS: A Pipe Dream? Plumb J, Holwell D, Burton R, Steer PJ. Practising Midwife April 2007
An overview of the natural history of early onset group B streptococcal disease in the UK. Colbourn T, Gilbert R. Early Hum Dev. 2007 Mar;83(3):149-56.
Perinatal group B streptococcal disease Heath PT, Schuchat A. Best Pract Res Clin Obstet Gynaecol. 2007 Jun;21(3):411-24.
Carriage of group B streptococcus in pregnant women from Oxford, UK Jones N, Oliver K, Jones Y, Haines A, Crook D. J Clin Pathol. 2006 Apr;59(4):363-6.
Could peripartum antibiotics have delayed health consequences for the infant? Bedford Russell AR, Murch SH. BJOG. 2006 Jul;113(7):758-65.
Pyogenic and non-pyogenic streptococcal bacteraemia, England, Wales and Northern Ireland: 2004. Commun Dis Rep Wkly 2005;15(24): Bacteraemia
The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. Law MR, Palomaki G, Alfirevic Z, Gilbert R, Heath P, McCartney C, Reid T, Schrag S. Journal of Medical Screening, 2005.
The effect of prepartum antibiotics on the type of neonatal bacteraemia: insights from the MRC ORACLE trials. Gilbert RE, Pike K, Kenyon SL, Tarnow-Mordi W, Taylor DJ. British Journal of Obstetrics & Gynaecology, June 2005.
Vaccination against Group B streptococcus. Heath PT, Feldman RG. Expert Review Vaccines, April 2005.
Pyogenic and non-pyogenic streptococcal bacteraemia, England, Wales and Northern Ireland: 2003. Commun Dis Rep Wkly 2004; 13(16): Bacteraemia
Early-onset neonatal group B streptococcal infection in London: 1990-1999. Mifsud AJ, Efstratiou A, Charlett A, McCartney AC; Health Protection Agency Group B Streptococcus Working GroupBritish Journal of Obstetrics & Gynaecology, September 2004.
Characterization of group B streptococci recovered from infants with invasive disease in England and WalesWeisner AM, Johnson AP, Lamagni TL, Arnold E, Warner M, Heath PT, Efstratiou A. Clin Infect Dis. 2004 May 1;38(9):1203-8.
Antenatal screening and intrapartum management of Group B Streptococcus in the UK. Kenyon S, Brocklehurst P, Blackburn A, Taylor DJ. British Journal of Obstetrics & Gynaecology, March 2004.
Group B streptococcal disease in UK and Irish infants younger than 90 days. Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, O’Connell LA, Cafferkey M, Verlander NQ, Nicoll A, McCartney AC; PHLS Group B Streptococcus Working Group.Lancet, January 2004.
Pyogenic and non-pyogenic streptococcal bacteraemia, England, Wales and Northern Ireland: 2002. Commun Dis Rep Wkly 2003; 13(16): Bacteraemia
Estimated early-onset group B streptococcal neonatal disease. Luck S, Torny M, d’Agapeyeff K, Pitt A, Heath P, Breathnach A, Russell AB. Lancet, June 2003.
Pyogenic and non-pyogenic streptococcal bacteraemia, England and Wales, 2001. Commun Dis Rep Wkly 2002; 12(16): Bacteraemia
Risk factors for early onset neonatal group B streptococcal sepsis: case-control study. Sam Oddie, Nicholas D Embleton, on behalf of the Northern Neonatal Network. BMJ, August 2002
Maternal screening to prevent neonatal Group B streptococcal disease. J Med Screen 2002;9:191
Prevention of early onset neonatal GBS infection. McCartney AC. Journal of Medical Screening, 2001.
Fetal and neonatal death from maternally acquired infection. Embleton, N, The Northern Region’s Perinatal Mortality Survey (2001). Paediatric and Perinatal Epidemiology 15 (1) , 54–60 doi:10.1046/j.1365-3016.2001.00314.x January 2001
Variations in the investigation and management of group B streptococcus in Scotland. Moss HJ, Mathers AM, Björnsson S, Cameron AD, Williams J, Pell J. Journal of Obstetrics & Gynaecology, 21(1):21-3. January 2001.
Neonatal group B streptococcal infection in South Bedfordshire, 1993-1998. Kathryn Beardsall, M H Thompson, R J Mulla. Arch Dis Child Fetal Neonatal Ed. 2000 May
Mortality from early onset group B streptococcal infection in the United Kingdom. Embleton N. Arch Dis Child Fetal Neonatal Ed, March 1999
Prevention of group B streptococcal infection in neonates Feldman RG. Curr Opin Infect Dis. 1998 Jun;11(3):325-9.
The Prevention of Early-Onset Neonatal Group B Streptococcal Disease. Money D, Allen VM. The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. JOGC. 2018 Aug;40(8):e665-674. DOI: https://doi.org/10.1016/j.jogc.2018.05.032
Risk factors for neonatal early-onset group B streptococcus-related diseases after the implementation of a universal screening program in Taiwan. Hung LC, Kung PT, Chiu TH, Su HP, Ho M, Kao HF, Chiu LT, Huang KH, Tsai WC. BMC Public Health. 2018 Apr 2;18(1):438. doi: 10.1186/s12889-018-5358-0.
Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics. Vekemans J, Moorthy V, Friede M, Alderson MR, Sobanjo-Ter Meulen A, Baker CJ, Heath PT, Madhi SA, Mehring-Le Doare K, Saha SK, Schrag S, Kaslow DC. Vaccine. 2018 Feb 2. pii: S0264-410X(17)31359-2. doi: 10.1016/j.vaccine.2017.09.087.
Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates? Lawn JE; Bianchi-Jassir F; Russell NJ; Kohli-Lynch M; Tann CJ. Clin Inf Dis, Vol 65, Iss supp2, 6 Nov 2017, ppS89–S99, https://doi.org/10.1093/cid/cix653
Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Russell NJ, Seale AC, O’Driscoll M, O’Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, Lawn JE, Baker CJ, Bartlett L, Cutland C. Clin Inf Dis, Vol 65, Iss supp2, 6 Nov 2017, ppS100–S111, https://doi.org/10.1093/cid/cix658
Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses. Seale AC; Blencowe H; Bianchi-Jassir F; Embleton N; Bassat Q. Clin Inf Dis, Vol 65, Iss supp2, 6 Nov 2017, ppS125–S132, https://doi.org/10.1093/cid/cix585
Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses. Bianchi-Jassir F; Seale AC; Kohli-Lynch M; Lawn JE; Baker CJ. Clin Inf Dis, Vol 65, Iss supp2, 6 Nov 2017, ppS133–S142, https://doi.org/10.1093/cid/cix661
Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review. Le Doare K; O’Driscoll M; Turner K; Seedat F; Russell NJ. Clin Inf Dis, Vol 65, Iss supp2, 6 Nov 2017, ppS143–S151, https://doi.org/10.1093/cid/cix654
Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses. Russell NJ; Seale AC; O’Sullivan C; Le Doare K; Heath PT. Clin Inf Dis, Vol 65, Iss supp2, 6 Nov 2017, ppS152–S159, https://doi.org/10.1093/cid/cix655
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses. Madrid L; Seale AC; Kohli-Lynch M; Edmond KM; Lawn JE. Clin Inf Dis, Vol 65, Iss supp2, 6 Nov 2017, ppS160–S172, https://doi.org/10.1093/cid/cix656
Neonatal Encephalopathy With Group B Streptococcal Disease Worldwide: Systematic Review, Investigator Group Datasets, and Meta-analysis. Tann CJ; Martinello KA; Sadoo S; Lawn JE; Seale AC. Clin Inf Dis, Vol 65, Iss supp2, 6 Nov 2017, ppS173–S189, https://doi.org/10.1093/cid/cix662
Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Hall J, Hack Adams N, Bartlett L, Seale AC, Lamagni T, Bianchi-Jassir F, Lawn JE, Baker CJ, Cutland C, Heath PT. Clin Inf Dis, Vol 65, Iss supp2, 6 Nov 2017, ppS112–S124, https://doi.org/10.1093/cid/cix660
Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses. Kohli-Lynch M; Russell NJ; Seale AC; Dangor Z; Tann CJ. Clin Inf Dis, Vol 65, Iss supp2, 6 Nov 2017, ppS190–S199, https://doi.org/10.1093/cid/cix663
Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children. Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, Madrid L, Blencowe H, Cousens S, Baker CJ. Clin Inf Dis, Vol 65, Iss supp2, 6 Nov 2017, ppS200–S219, https://doi.org/10.1093/cid/cix664
Antibiotic Prevention for Maternal Group B Streptococcal Colonization on Neonatal GBS-Related Adverse Outcomes: A Meta-Analysis. Li S, Huang J, Chen Z, Guo D, Yao Z, Xiaohue Y. Front Microbiol. 2017 Mar 17;8:374. doi: 10.3389/fmicb.2017.00374. eCollection 2017
Prevention of early onset group B streptococcal disease by universal antenatal culture-based screening in all public hospitals in Hong Kong. Ma TW, Chan V, So CH, Hui AS, Lee CN, Hui AP, So PL, Kong CW, Fung B, Leung KY. J Matern Fetal Neonatal Med. 2017 Mar 21:1-7.
Group B streptococcal disease in infants in the first year of life: a nationwide surveillance study in Japan, 2011-2015. Matsubara K, Hoshina K, Kondo M, Miyairi I, Yukitake Y, Ito Y, Minami K, Genkawa R. Infection. 2017 Feb 25. doi: 10.1007/s15010-017-0995-2.
Group B Streptococci screening before repeat Cesarean delivery: A cost-effectiveness analysis. Albright, C., MacGregor, C., Sutton, D., Theva, M., Hughes, B. and Werner, E. (2016). Obstetrics and gynecology., 2017 Jan;129(1):111-119.
The prevention of early-onset neonatal group B Streptococcal disease. Money, D. and Allen, V. (2017), Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC., 38.
Obesity as an independent risk factor for group B streptococcal colonization. Alvareza MD, Subramaniam A, Tang Y, Edwards RK. J Matern Fetal Neonatal Med. 2016 Dec 20:1-4.
Risk factors for group B streptococcal disease in neonates of mothers with negative antenatal testing. Parente V, Clark RH, Ku L, Fennell C, Johnson M, Morris E, Romaine A, Utin U, Benjamin DK, Messina JA, Smith PB, Greenberg RG. J Perinatol. 2017 Feb;37(2):157-161. doi: 10.1038/jp.2016.201. Epub 2016 Nov 17.
Risk Factors for Late-Onset Group B Streptococcal Disease Before and After Implementation of Universal Screening and Intrapartum Antibiotic Prophylaxis. Pintye J, Saltzman B, Wolf E, Crowell CS. J Pediatric Infect Dis Soc. 2016 Dec;5(4):431-438. Epub 2015 Oct 12.
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries. Kobayashi M, Vekemans J, Baker CJ, Ratner AJ, Le Doare K, Schrag SJ. F1000Res. 2016 Sep 22;5:2355. eCollection 2016.
WHO consultation on group B vaccine development: Report from a meeting held on 27–28 April 2016. (2017) Kobayashi, M., Schrag, S.J., Alderson, M.R., Madhi, S.A., Baker, C.J., Meulen, A.S., Kaslow, D.C., Smith, P.G., Moorthy, V.S. and Vekemans, J. Vaccine, . doi: 10.1016/j.vaccine.2016.12.029.
Epidemiology of Invasive Early-Onset Neonatal Sepsis, 2005 to 2014. Schrag SJ, Farley MM, Petit S, Reingold A, Weston EJ, Pondo T, Hudson Jain J, Lynfield R. Pediatrics. 2016 Dec;138(6). pii: e20162013.
Challenges in reducing group B Streptococcus disease in African settings Nishihara, Y., Dangor, Z., French, N. and Madhi, S. (2017) Archives of Disease in Childhood, 102(1), pp. 72–77. doi: 10.1136/archdischild-2016-311419.
Early-onset neonatal sepsis and the implementation of group B streptococcus prophylaxis in a Brazilian maternity hospital: a descriptive study. Freitas FT, Romero GA. Braz J Infect Dis. 2017 Jan – Feb;21(1):92-97.
Replacing risk-based early-onset-disease prevention with intrapartum group B streptococcus PCR testing Björklund V, Nieminen T, Ulander VM, Ahola T, Saxén H. J Matern Fetal Neonatal Med. 2016 Mar 31:1-22.
Relative Importance and Additive Effects of Maternal and Infant Risk Factors on Childhood Asthma. Wu P, Feldman AS, Rosas-Salazar C, James K, Escobar G, Gebretsadik T, Li SX, Carroll KN, Walsh E, Mitchel E, Das S, Kumar R, Yu C, Dupont WD, Hartert T1. PLoS One. 2016 Mar 22;11(3):e0151705.
The changing epidemiology of group B streptococcus bloodstream infection: a multi-national population-based assessment. Ballard MS, Schønheyder HC, Knudsen JD, Lyytikäinen O, Dryden M, Kennedy KJ, Valiquette L, Pinholt M, Jacobsson G, Laupland KB; International Bacteremia Surveillance Collaborative. Infect Dis (Lond). 2016 May;48(5):386-91. Epub 2016 Jan 12.
Reductions in neonatal listeriosis: “Collateral benefit” of Group B streptococcal prophylaxis? Lee B, Newland JG, Jhaveri R. J Infect. 2016 Mar;72(3):317-23. doi: 10.1016/j.jinf.2015.12.015. Epub 2016 Jan 6.
Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial. Donders GG1, Halperin SA, Devlieger R, Baker S, Forte P, Wittke F, Slobod KS, Dull PM. Obstet Gynecol. 2016 Feb;127(2):213-21.
Maternal Immunization to Prevent Neonatal Group B Streptococcal Disease: New Progress and Promise. Schrag SJ. Obstet Gynecol. 2016 Feb;127(2):199-201.
Intrapartum antibiotic exposure for group B Streptococcus treatment did not increase penicillin allergy in children. May SM, Hartz MF, Joshi AY, Park MA. Ann Allergy Asthma Immunol. 2016 Feb;116(2):134-8.
En route towards prevention of neonatal group B streptococcal disease. Berner R. Lancet Infect Dis. 2016 Feb 8. pii: S1473-3099(15)00501-0.
Efficiency of Screening for the Recurrence of Antenatal Group B Streptococcus Colonization in a Subsequent Pregnancy: A Systematic Review and Meta-analysis with Independent Patient Data. Turrentine MA, Colicchia LC, Hirsch E, Cheng PJ, Tam T, Ramsey PS, Page-Ramsey SM. Am J Perinatol. 2015 Dec 18
Maternal colonization of group B streptococcus: prevalence, associated factors and antimicrobial resistance. Khan MA, Faiz A, Ashshi AM. Ann Saudi Med. 2015 Nov-Dec;35(6):423-7.
The prevention of early-onset neonatal group B streptococcus infection: New Zealand Consensus Guidelines 2014. Darlow B1, Campbell N, Austin N, Chin A, Grigg C, Skidmore C, Voss L, Walls T, Wise M, Werno A. N Z Med J. 2015 Nov 20;128(1425):69-76.
Evaluation of four chromogenic media for the isolation of Group B Streptococcus from vaginal specimens in pregnant women. Salem N, Anderson JJ. Pathology. 2015 Oct;47(6):580-2.
Risk Factors for Late-Onset Group B Streptococcal Disease Before and After Implementation of Universal Screening and Intrapartum Antibiotic Prophylaxis. Pintye J, Saltzman B, Wolf E, Crowell CS. J Pediatric Infect Dis Soc. 2015 Oct 12.
A Retrospective Audit of Clinically Significant Maternal Bacteraemia in a Specialist Maternity Hospital from 2001 to 2014. Drew RJ, Fonseca-Kelly Z, Eogan M. Infect Dis Obstet Gynecol. 2015:518562.
Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. Azad MB, Konya T, Persaud RR, Guttman DS, Chari RS, Field CJ, Sears MR, Mandhane PJ, Turvey SE, Subbarao P, Becker AB, Scott JA, Kozyrskyj AL; CHILD Study Investigators. BJOG. 2015 Sep 28.
A questionnaire study on the acceptability of self-sampling versus screening by clinicians for Group B Streptococcus. Ko JK, Yung SS, Seto MT, Lee CP. J Chin Med Assoc. 2015 Sep 15. pii: S1726-4901(15)00220-8.
Maternal Obesity and Rectovaginal Group B Streptococcus Colonization at Term. Kleweis SM, Cahill AG, Odibo AO, Tuuli MG. Infect Dis Obstet Gynecol. 2015:586767.
Maternal Colonization with Group B Streptococcus Is Associated with an Increased Rate of Infants Transferred to the Neonatal Intensive Care Unit. Brigtsen AK, Jacobsen AF, Dedi L, Melby KK, Fugelseth D, Whitelaw A. Neonatology. 2015;108(3):157-63.
Case Study of Intrapartum Antibiotic Prophylaxis and Subsequent Postpartum Beta-Lactam Anaphylaxis. Stark MA, Ross MF, Kershner W, Searing K. J Obstet Gynecol Neonatal Nurs. 2015 Sep-Oct;44(5):610-7.
Maternal group B Streptococcus-related stillbirth: a systematic review. Nan C1, Dangor Z, Cutland CL, Edwards MS, Madhi SA, Cunnington MC. BJOG. 2015 Oct;122(11):1437-45.
Maternal Obesity and Rectovaginal Group B Streptococcus Colonization at Term. Kleweis SM, Cahill AG, Odibo AO, Tuuli MG. Infect Dis Obstet Gynecol. 2015;2015:586767. doi: 10.1155/2015/586767. Epub 2015 Aug 2.
Early-onset neonatal group B streptococcus sepsis following national risk-based prevention guidelines. Darlow BA, Voss L, Lennon DR, Grimwood K. Aust N Z J Obstet Gynaecol. 2015 Jul 14.
Comparison of pre- and intrapartum screening of group B streptococci and adherence to screening guidelines: a cohort study. Kunze M, Zumstein K, Markfeld-Erol F, Elling R, Lander F, Prömpeler H, Berner R, Hufnagel M. Eur J Pediatr. 2015 Jun;174(6):827-35.
Group B Streptococcus vaccine: state of the art. Nuccitelli A, Rinaudo CD, Maione D. Ther Adv Vaccines. 2015 May;3(3):76-90.
Routine culture-based screening versus risk-based management for the prevention of early-onset group B streptococcus disease in the neonate: a systematic review. Kurz E, Davis D. JBI Database System Rev Implement Rep. 2015 Apr 17;13(3):206-46.
Screening and management of maternal colonization with Streptococcus agalactiae: an Italian cohort study. De Luca C, Buono N1, Santillo V, Licameli A, Straface G, Scambia G, De Santis M. J Matern Fetal Neonatal Med. 2016 Mar;29(6):911-5.
Vaginal group B streptococcus status during intrapartum antibiotic prophylaxis. Scasso S, Laufer J, Rodriguez G, Alonso JG, Sosa CG. Int J Gynaecol Obstet. 2015 Apr;129(1):9-12. doi: 10.1016/j.ijgo.2014.10.018. Epub 2014 Dec 18.
Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection. Ohlsson A1, Shah VS, Stade BC. Cochrane Database Syst Rev. 2014 Dec 14;12:CD003520.
Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study. Bekker V, Bijlsma MW, van de Beek D, Kuijpers TW, van der Ende A. Lancet Infect Dis. 2014 Nov;14(11):1083-9. doi: 10.1016/S1473-3099(14)70919-3. Epub 2014 Oct 19.
Recurrence of group B streptococcus colonization in successive pregnancies. Colicchia LC, Lauderdale DS, Du H, Adams M, Hirsch E. J Perinatol. 2014 Oct 16. doi: 10.1038/jp.2014.185.
Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. Di Renzo GC, Melin P, Berardi A, Blennow M, Carbonell-Estrany X, Donzelli GP, Hakansson S, Hod M, Hughes R, Kurtzer M, Poyart C, Shinwell E, Stray-Pedersen B, Wielgos M, El Helali N. J Matern Fetal Neonatal Med. 2014 Aug 27:1-17.
Does Maternal Intrapartum Antibiotic Treatment Prolong the Incubation Time Required for Blood Cultures to Become Positive for Infants with Early-Onset Sepsis? Sarkar SS, Bhagat I, Bhatt-Mehta V, Sarkar S. Am J Perinatol. 2014 Sep 13.
Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. Tajik P, van der Ham DP, Zafarmand MH, Hof MH, Morris J, Franssen MT, de Groot CJ, Duvekot JJ, Oudijk MA, Willekes C, Bloemenkamp KW, Porath M, Woiski M, Akerboom BM, Sikkema JM, Nij Bijvank B, Mulder AL, Bossuyt PM, Mol BW. BJOG. 2014 Sep;121(10):1263-72; discussion 1273. doi: 10.1111/1471-0528.12889. Epub 2014 May 27.
Impact of Perinatal Practices for Early-onset Group B Streptococcal Disease Prevention. Berardi A, Lugli L, Rossi C, Guidotti I, Lanari M, Creti R, Perrone E, Biasini A, Sandri F, Volta A, China M, Sabatini L,Baldassarri L, Vagnarelli F, Ferrari F; on behalf of the GBS Prevention Working Group, Emilia-Romagna. Pediatr Infect Dis J. 2013 Jul;32(7):e265-e271.
Early-onset and late-onset group B streptococcal disease in Japan: a nationwide surveillance study, 2004-2010. Matsubara K, Hoshina K, Suzuki Y.
Int J Infect Dis. 2013 Jun;17(6):e379-84. doi: 10.1016/j.ijid.2012.11.027.
Screening pregnant women for group B streptococcus infection between 30 and 32weeks of pregnancy in a population at high risk for premature birth. Horváth B, Grasselly M, Bödecs T, Boncz I, Bódis J. Int J Gynaecol Obstet. 2013 Jul;122(1):9-12. doi: 10.1016/j.ijgo.2013.01.027. Epub 2013 Apr 8.
Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Fairlie T, Zell ER, Schrag S. Obstet Gynecol. 2013 Mar;121(3):570-7. doi: 10.1097/AOG.0b013e318280d4f6.
Antibiotic resistance patterns among group B Streptococcus isolates: implications for antibiotic prophylaxis for early-onset neonatal sepsis. Capanna, Federica. Emonet, Stephane P. Cherkaoui, Abdessalam. et al. Swiss Med Wkly. 2013;143:w13778
Physical Examination Instead of Laboratory Tests for Most Infants Born to Mothers Colonized with Group B Streptococcus: Support for the Centers for Disease Control and Prevention’s 2010 Recommendations. Cantoni L, Ronfani L, Da Riol R, Demarini S; Perinatal Study Group of the Region Friuli-Venezia Giulia. J Pediatr. 2013 Mar 8. pii: S0022-3476(13)00109-1. doi: 10.1016/j.jpeds.2013.01.034.
Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis.Turrentine MA, Greisinger AJ, Brown KS, Wehmanen OA, Mouzoon ME. Infect Dis Obstet Gynecol. 2013;2013:525878. doi: 10.1155/2013/525878. Epub 2013 Mar 28.
Accuracy of an Accelerated, Culture-Based Assay for Detection of Group B Streptococcus Jonathan P. Faro, , Karen Bishop, Gerald Riddle, Mildred M. Ramirez, Allan R. Katz, Mark A. Turrentine, Sebastian Faro. Infect Dis Obstet Gynecol. 2013; 2013: 367935. Published online 2013 February 19. doi: 10.1155/2013/367935
Prevalence of positive recto-vaginal culture for Group B streptococcus in pregnant women at 35-37 weeks of gestation. Forough Javanmanesh, Nooshin Eshraghi. Med J Islam Repub Iran. 2013 February; 27(1): 7–11.
Early onset neonatal group B streptococcal sepsis.Oh W. Am J Perinatol. 2013 Feb;30(2):143-7. doi: 10.1055/s-0032-1332804. Epub 2013 Jan 15
Usefulness of a rapid real-time PCR assay in prenatal screening for group B streptococcus colonization. Park JS, Cho DH, Yang JH, Kim MY, Shin SM, Kim EC, Park SS, Seong MW. Ann Lab Med. 2013 Jan;33(1):39-44. doi: 10.3343/alm.2013.33.1.39. Epub 2012 Dec 17.
Incidence of maternal GBS colonization and neonatal GBS disease among very low birth weight Polish neonates. Brzychczy-Wloch M, Wojkowska-Mach J, Helwich E, Heczko PB. Med Sci Monit. 2013 Jan 11;19:34-9.
Intrapartum antibiotics for known maternal Group B streptococcal colonization. Ohlsson A, Shah VS. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD007467. DOI: 10.1002/14651858.CD007467.pub3.
Group B Streptococcus Late-Onset Disease: 2003-2010. Berardi A, Rossi C, Lugli L, Creti R, Bacchi Reggiani ML, Lanari M, Memo L, Pedna MF, Venturelli C, Perrone E, Ciccia M, Tridapalli E, Piepoli M, Contiero R, Ferrari F; on behalf of the GBS Prevention Working Group, Emilia-Romagna.Pediatrics. 2013 Jan 6.
Short communication: A comparative study assessing the efficacy and acceptability of anorectal swabs for antenatal GBS screening. Law KS, Parmar P, Gregora M, Abbott J. J Med Screen. 2013 Mar 25.
Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine. Schrag SJ, Verani JR. Vaccine. 2012 Dec 3. pii: S0264-410X(12)01697-0
Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination. Edwards MS, Gonik B. Vaccine. 2012 Nov 28. pii: S0264-410X(12)01660-X. doi: 10.1016/j.vaccine.2012.11.046.
[A study on early-onset group “B” streptococcal neonatal infection]. Vacheva R, Todorova M, Decheva A, Yarakova N, Kraleva I, Takova Ts, Dimitrova N, Dobreva A. Akush Ginekol (Sofiia). 2012;51(6):10-21.
Prevalence of Group B Streptococcus Colonization in Subsequent Pregnancies of Group B Streptococcus-Colonized versus Noncolonized Women. Page-Ramsey SM, Johnstone SK, Kim D, Ramsey PS. Am J Perinatol. 2012 Sep 21.
Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group b streptococcal disease. Lin F-Y. The Pediatric infectious disease journal. 2011 Sep 30(9):759-63.
Improving perinatal Group B streptococcus screening with process indicators. Albouy-Llaty M, Nadeau C, Descombes E, Pierre F, Migeot V. J Eval Clin Pract. 2012 Aug;18(4):727-33. doi: 10.1111/j.1365-2753.2011.01658.x. Epub 2011 Mar 18.
Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B Streptococcal disease. Stafford IA, Stewart RD, Sheffield JS, Wendel GD Jr, Sanchez PJ, McIntire DD, Roberts SW. Obstet Gynecol. 2012 Jul;120(1):123-9.
The impact of group B streptococcus prophylaxis on late-onset neonatal infections. Ecker KL, Donohue PK, Kim KS, Shepard JA, Aucott SW. J Perinatol. 2012 Jun 14. doi: 10.1038/jp.2012.76.
Long-term Outcomes of Group B Streptococcal Meningitis. Libster R, Edwards KM, Levent F, Edwards MS, Rench MA, Castagnini LA, Cooper T, Sparks RC, Baker CJ, Shah PE. Pediatrics. 2012 Jul;130(1):e8-e15. Epub 2012 Jun 11.
Prevention of Neonatal Group B Sreptococcal Infection. Spanish Recommendations. Update 2012. SEIMC/SEGO/SEN/SEQ/SEMFYC Consensus Document. Alós Cortés JI, Andreu Domingo A, Arribas Mir L,Cabero Roura L, de Cueto López M, López Sastre J, Melchor Marcos JC, Puertas Prieto A, de la Rosa Fraile M,Salcedo Abizanda S, Sánchez Luna M, Sanchez Pérez MJ, Torrejon Cardoso R. Enferm Infecc Microbiol Clin.2012 Jun 1.
GBS Screening. N Walker. June 2012. O&G Vol 14:No 2:Winter 2012.
Management of group B streptococcal bacteriuria in pregnancy. Allen VM, Yudin MH, Bouchard C, Boucher M, Caddy S, Castillo E, Money DM, Murphy KE, Ogilvie G, Paquet C, van Schalkwyk J, Senikas V; Infectious Diseases Committee, Society of Obstetricians and Gynaecologists of Canada. J Obstet Gynaecol Can. 2012 May;34(5):482-6.
Bacteruria with group-B streptococcus: is it a risk factor for adverse pregnancy outcomes? Kessous R, Weintraub AY, Sergienko R, Lazer T, Press F, Wiznitzer A, Sheiner E. J Matern Fetal Neonatal Med. 2012 Apr 25.
Recolonization of gropu B Streptococcus (GBS) in women with prior GBS genital colonization in pregnancy.Tam T, Bilinski E, Lombard E. J Matern Fetal Neonatal Med. 2012 Apr 2
Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Stoll BJ, Hansen NI, Sánchez PJ, Faix RG, Poindexter BB, Van Meurs KP, Bizzarro MJ, Goldberg RN, Frantz ID 3rd, Hale EC, Shankaran S, Kennedy K, Carlo WA, Watterberg KL, Bell EF, Walsh MC, Schibler K, Laptook AR, Shane AL, Schrag SJ, Das A, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Pediatrics. 2011 May;127(5):817-26. Epub 2011 Apr 25.
International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci). Afshar B, Broughton K, Creti R, Decheva A, Hufnagel M, Kriz P, Lambertsen L, Lovgren M, Melin P, Orefici G, Poyart C, Radtke A, Rodriguez-Granger J, Sørensen UB, Telford J, Valinsky L, Zachariadou L; Members of the DEVANI Study Group, Efstratiou A. Clin Microbiol. 2011 Apr;49(4):1475-82. Epub 2011 Feb 16.
Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project. Rodriguez-Granger J, Alvargonzalez JC, Berardi A, Berner R, Kunze M, Hufnagel M, Melin P, Decheva A, Orefici G, Poyart C, Telford J, Efstratiou A, Killian M, Krizova P, Baldassarri L, Spellerberg B, Puertas A, Rosa-Fraile M. Eur J Clin Microbiol Infect Dis. 2012 Feb 8
The Prevalence of Vaginal Microorganisms in Pregnant Women with Preterm Labor and Preterm Birth. Seong Jin Choi, M.D. Soon Deok Park, M.S. In Ho Jang, M.S. Young Uh, M.D. and Anna Lee, M.D. Ann Lab Med 2012;32:194-200. 2012 Feb/
Screening for group B Streptococcus in pregnancy women: a systematic review and meta-analysis. M Taminato, D Fram, MR Torloni, AG Belasco, H Saconato, DA Barbosa. Dec 2011. Rev Lat Am Enfermagem
Horizontal transmission of group B streptococcus in a neonatal intensive care unit. Morinis J, Shah J, Murthy P, Fulford M. Paediatr Child Health. 2011 Jun;16(6):e48-50.
Prevention of Perinatal Group B Streptococcal Disease. Revised Guidelines from CDC, 2010. Recommendations and Reports. November 19, 2010 / 59(RR10);1-32
Development of a Rapid PCR Assay for Screening of Maternal Colonization by Group B Streptococcus and Neonatal Invasive Escherichia coli during Labor Martínez de Tejada B, Stan CM, Boulvain M, Renzi G, François P, Irion O, Schrenzel J. Gynecol Obstet Invest. 2010 Oct 16;70(4):250-255.
Incidence and distribution of pathogens in early-onset neonatal sepsis in the era of antenatal antibiotics. Kuhn P et al Paediatr Perinat Epidemiol. 2010 Sep;24(5):479-87
Group B streptococcus: prevalence in a non-obstetric population. Leclair CM, Hart AE, Goetsch MF, Carpentier H, Jensen JT. J Low Genit Tract Dis. 2010 Jul;14(3):162-6.
The accuracy of late third-trimester antenatal screening for group B streptococcus in predicting colonization at delivery. Towers CV, Rumney PJ, Asrat T, Preslicka C, Ghamsary MG, Nageotte MP. Am J Perinatol. 2010 Nov;27(10):785-90. Epub 2010 May 10.
No Change in the Incidence of Ampicillin-Resistant, Neonatal, Early-Onset Sepsis Over 18 Years. Puopolo KM, Eichenwald EC. Pediatrics. 2010 Apr 12.
Late and ultra late onset Streptococcus B meningitis: clinical and bacteriological data over 6 years in France. Guilbert J, Levy C, Cohen R; Bacterial meningitis group, Delacourt C, Renolleau S, Flamant C. Acta Paediatr. 2010 Jan;99(1):47-51.
Timing of group B streptococcus screening in pregnancy: a systematic review. Valkenburg-van den Berg AW, Houtman-Roelofsen RL, Oostvogel PM, Dekker FW, Dörr PJ, Sprij AJ. Gynecol Obstet Invest. 2010;69(3):174-83.
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Cutland CL, Madhi SA, Zell ER, Kuwanda L, Laque M, Groome M, Gorwitz R, Thigpen MC, Patel R, Velaphi SC, Adrian P, Klugman K, Schuchat A, Schrag SJ; PoPS Trial Team. Lancet. 2009 Dec 5;374(9705):1909-16.
Women Receiving Group B Streptococcus Serotype III Tetanus Toxoid (GBS III-TT) Vaccine Have Reduced Vaginal and Rectal Acquisition of GBS Type III. Hillier S, Ferris D, Fine P, Ferrieri P, Edwards M, Carey V, Ewell M, Meyn L, Paoletti L, Kasper D, Baker C. Presented on 30 October 2009 at the 47th Annual Meeting of the Infectious Diseases Society of America
Group B streptococcal meningitis: cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis. Ansong AK et al. Early Hum Dev 2009 Oct;85(10 Suppl);S5-7. Epub 2009 Sep 19.
Evaluation of universal antenatal screening for group B streptococcus. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, Mohle-Boetani J, Gershman K, Schaffner W, Petit S, Zansky SM, Morin CA, Spina NL, Wymore K, Harrison LH, Shutt KA, Bareta J, Bulens SN, Zell ER, Schuchat A, Schrag SJ. N Engl J Med. 2009 Jun 18;360(25):2626-36.
Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Koenig JM, Keenan WJ. Pediatr Clin North Am. 2009 Jun;56(3):689-708,
Inappropriate use of vancomycin for preventing perinatal group B streptococcal (GBS) disease in laboring patients. Peláez LM, Gelber SE, Fox NS, Chasen ST. J Perinat Med. 2009 Jun 3.
Patient self-collection of group B streptococcal specimens during pregnancy. J Am Board Fam Med. 2009 Mar-Apr;22(2):136-40. Hicks P, Diaz-Perez MJ.
Evaluation of three selective enrichment media for detection of Group B Streptococcus in vaginal swabs. Kansenshogaku Zasshi. 2009 Jan;83(1):52-5. Shibuya R, Yamashita T, Shibuya S, Hasegawa M, Kanayama A, Ikeda F, Kobayashi I, Tsuji A, Yamaguchi K.
Trends in Perinatal Group B Streptococcal Disease — United States, 2000–2006. Centers for Disease Control and Prevention (CDC). MMWR Weekly. February 13, 2009 / 58(05);109-112
The accuracy of late antenatal screening cultures in predicting intrapartum group B streptococcal colonization. Kovavisarach E, Jarupisarnlert P, Kanjanaharuetai S. J Med Assoc Thai. 2008 Dec;91(12):1796-800.
Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease: A Multistate, Population-Based Analysis. Pediatr Infect Dis J. 2008 Nov 4. Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, Lynfield R, Thomas A, Zansky S, Gershman K, Albanese BA, Schaffner W, Schrag SJ; for CDCʼs Active Bacterial Core Surveillance (ABCs) / Emerging Infections Program Network.
Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum Vaccin. 2008 Nov-Dec;4(6):444-8. Edwards MS.
Acquisition and transmission of group B Streptococcus during pregnancy. J Infect Dis. 2008 Nov 1;198(9):1375-8. Foxman B, de Azevedo CL, Buxton M, DeBusscher J, Pillai P, De Carvalho NS, Barbosa-Cesnik C.
The Effect of Universal Maternal Screening on the Incidence of Neonatal Early-Onset Group B Streptococcal Disease. Clin Pediatr (Phila). 2008 Oct 2. Eberly MD, Rajnik M.
Group B Streptococcus colonization in pregnancy: prevalence and prevention strategies of neonatal sepsis. J Perinat Med. 2008 Oct 31. Rausch AV, Gross A, Droz S, Bodmer T, Surbek DV
An evaluation of a rapid real time polymerase chain reaction assay for detection of group B streptococcus as part of a neonatal group B streptococcus prevention strategy. Money D, Dobson S, Cole L, Karacabeyli E, Blondel-Hill E, Milner R, Thomas E. J Obstet Gynaecol Can. 2008 Sep;30(9):770-5.
Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis. J Perinatol. 2008 Aug 14. Pulver LS, Hopfenbeck MM, Young PC, Stoddard GJ, Korgenski K, Daly J, Byington CL.
Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery. Obstet Gynecol. 2008 Aug;112(2 Pt 1):265-70. Barber EL, Zhao G, Buhimschi IA, Illuzzi JL.
Recurrence of group B streptococci colonization in subsequent pregnancy. Turrentine MA, Ramirez MM. Obstet Gynecol. 2008 Aug;112(2 Pt 1):259-64.
Prévention de l’infection néonatale à Streptocoques du groupe B à début précoce. Surbek D, Gross A, Seydoux J, Honegger C, Irion O, Drack G . 2008.
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ; Active Bacterial Core surveillance/Emerging Infections Program Network. JAMA. 2008 May 7;299(17):2056-65.
Prenatal antibiotic treatment does not decrease group B streptococcus colonization at delivery. Baecher L, Grobman W. Int J Gynaecol Obstet. 2008 May;101(2):125-8. Epub 2007 Dec 20.
Risk factors for recurrence of group B streptococcus colonization in a subsequent pregnancy. Cheng PJ, Chueh HY, Liu CM, Hsu JJ, Hsieh TT, Soong YK. Obstet Gynecol. 2008 Mar;111(3):704-9.
Prevalence of maternal group B streptococcal colonisation in European countries. Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, Nadisauskiene R. Acta Obstet Gynecol Scand. 2008;87(3):260-71.
Self-collected versus health professional-collected genital swabs to identify the prevalence of group B streptococcus: A comparison of patient preference and efficacy. Arya A, Cryan B, O’Sullivan K, Greene RA, Higgins JR. Eur J Obstet Gynecol Reprod Biol. 2008 Feb 4.
Comparison of combined vaginal-anorectal, vaginal and anorectal cultures in detecting of group B streptococci in pregnant women in labor. Kovavisarach E, Sa-adying W, Kanjanahareutai S. J Med Assoc Thai. 2007 Sep;90(9):1710-4.
Institution of universal screening for Group B streptococcus (GBS) from a risk management protocol results in reduction of early-onset GBS disease in a tertiary obstetric unit. Angstetra D, Ferguson J, Giles WB. Aust N Z J Obstet Gynaecol. 2007 Oct;47(5):378-82.
Epidemiology of early-onset neonatal group B streptococcal infection: implications for screening. Konrad G, Katz A. Can Fam Physician. 2007 Jun;53(6):1055, 2001:e.1-6, 1054.
Prevention of neonatal group B streptococcal infection: approaches of physicians in Winnipeg, Man. Konrad G, Hauch S, Pylypjuk C. Can Fam Physician. 2007 Feb;53(2):290, 289:e.1-5, 289.
Management of group B Streptococcus in pregnant women with penicillin allergy. Philipson EH, Lang DM, Gordon SJ, Burlingame JM, Emery SP, Arroliga ME. J Reprod Med. 2007 Jun;52(6):480-4.
Perinatal group B streptococcal disease after universal screening recommendations–United States, 2003-2005. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2007 Jul 20;56(28):701-5.
Selective versus non-selective culture medium for group B streptococcus detection in pregnancies complicated by preterm labor or preterm-premature rupture of membranes. Nomura ML, Passini Júnior R, Oliveira UM. Braz J Infect Dis. 2006 Aug;10(4):247-50.
Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention. Trijbels-Smeulders M, de Jonge GA, Pasker-de Jong PC, Gerards LJ, Adriaanse AH, van Lingen RA, Kollée LA. Arch Dis Child Fetal Neonatal Ed. 2007 Jul;92(4):F271-6. Epub 2007 Jan 16.
Evaluation of polymerase chain reaction for group B streptococcus detection using an improved culture method. Atkins KL, Atkinson RM, Shanks A, Parvin CA, Dunne WM, Gross G. Obstet Gynecol. 2006 Sep;108(3 Pt 1):488-91.
Maternal anxiety about prenatal screening for group B streptococcus disease and impact of positive colonization results. Cheng PJ, Shaw SW, Lin PY, Huang SY, Soong YK. Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):29-33. Epub 2006 Mar 2.
Early-onset and late-onset neonatal group B streptococcal disease–United States, 1996-2004. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2005 Dec 2;54(47):1205-8.
Early-Onset Group B Streptococcal Disease in the Era of Maternal Screening. Obstet Gynecol Surv. 2005 Oct
Group B streptococcus disease in neonates: To screen or not to screen? J Obstet Gynaecol. 2005 Jul
Efficacy of intramuscular penicillin in the eradication of group B streptococcal colonization at delivery. Pinette MG, Thayer K, Wax JR, Blackstone J, Cartin A. J Matern Fetal Neonatal Med. 2005 May.
Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention. Acta Paediatr. 2005 Apr
Antenatal screening for Group B Streptococcus: A diagnostic cohort study. BMC Pregnancy Childbirth. 2005 Jul
Clinical features and epidemiology of septicaemia and meningitis in neonates due to Streptococcus agalactiae in Copenhagen County, Denmark: a 10 year survey from 1992 to 2001. Andersen J, Christensen R, Hertel J. Acta Paediatr. 2004 Oct;93(10):1334-9.
Trends in sepsis-related neonatal mortality in the United States, 1985-1998. Pediatr Infect Dis J. 2004 Jul
Ten-year study on the effect of intrapartum antibiotic prophylaxis on early onset group B streptococcal and Escherichia coli neonatal sepsis in Australasia. Daley et al. Pediatr Infect Dis J. 2004
Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection. Stade BC, Shah VS, Ohlsson A. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No: CD003520. DOI: 10.1002/14651858.CD003520.pub2.
Active surveillance of early onset disease due to group B streptococci in newborns. Straková L, Motlová J. Indian J Med Res, 2004 May;119 Suppl;205-7
High burden of invasive Streptococcus agaaciae disease in South African infants. Madhi SA Radebe K et al Ann Trop Paediatr 2003 Mar;23(1):15-23
Decreasing incidence of perinatal group B streptococcal disease (Barcelona 1994-2002). Relation with hospital prevention policies. Enferm Infecc Microbiol Clin. 2003
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. Schrag SJ, Zell ER, Lynfield R,et al;Active Bacterial Core Surveillance Team. N Engl J Med. 2002 Jul 25;347(4):233-9.
Impact of different prevention strategies on neonatal group B streptococcal disease. Am J Perinatol. 2002
Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001
Late third-trimester treatment of rectovaginal group B streptococci with benzathine penicillin G. Am J Obstet Gynecol. 2000 Aug;183(2):372-6.
Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 2000 Aug;106(2 Pt 1):377-8.
The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Petitti DB. Pediatrics, 2000 Aug;106(2 Pt 1):244-50
Intrapartum antibiotics and early onset neonatal sepsis caused by group B streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections Pediatr Infect Dis J 1999
Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Benitz WE, Gould JB, Druzin ML. .l literature review. Pediatrics 1999; 103(6):e77.
Acute bacterial meningitis in children admitted to the Queen Elizabeth Central Hospital, Blantyrem, Malawi in 1996-97. Molyneux E, Walsh A, Phiri A, Molyneux M. Trop Med Int Health 1998 Aug;3(8):610-8.
Can pregnant women obtain their own specimens for group B streptococcus? A comparison of maternal versus physician screening. The Mount Sinai GBS Screening Group. Molnar P, Biringer A, McGeer A, McIsaac W. Fam Pract. 1997 Oct;14(5):403-6.
The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. Obstet Gynecol. 1996 Nov;88(5):811-5. Am J Obstet Gynecol. 1984 Apr 1;148(7):915-28.
Group B Streptococcal disease; its importance in the developing world and prospect for prevention with vaccines. Walsh JA Hutchins S. Pediatr Infect Dis J 1989 May;8(5):271-7.
Bacterial attachment to the chorioamniotic membranes. Galask RP, Varner MW, Petzold CR, Wilbur SL.
Long-term sequelae of group B streptococcal meningitis in infants. MS Edwards, MA Rench, A Haffar, M Murphy, M Desmond, C Baker. The Journal of Pediatrics, May 1985 Vol 106:5 P 717-722
